NAAA is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth

Autor: Barbara Romano 1 2, Ester Pagano 1 2, Fabio A Iannotti 3 2, Fabiana Piscitelli 3 2, Vincenzo Brancaleone 4, Giuseppe Lucariello 1, Maria Francesca Nanì 1 2, Ferdinando Fiorino 1, Rosa Sparaco 1, Giovanna Vanacore 1, Federica Di Tella 1, Donatella Cicia 1, Ruggero Lionetti 5, Alexandros Makriyannis 6, Michael Malamas 6, Marcello De Luca 5, Giovanni Aprea 7, Maria D'Armiento 8, Raffaele Capasso 9 2, Bernardo Sbarro 1, Tommaso Venneri 1 2, Vincenzo Di Marzo 3 10 11 2, Francesca Borrelli 1 2, Angelo A Izzo 1 2

Publikováno v: British journal of pharmacology (2021).
info:cnr-pdr/source/autori:Barbara Romano 1 2, Ester Pagano 1 2, Fabio A Iannotti 3 2, Fabiana Piscitelli 3 2, Vincenzo Brancaleone 4, Giuseppe Lucariello 1, Maria Francesca Nanì 1 2, Ferdinando Fiorino 1, Rosa Sparaco 1, Giovanna Vanacore 1, Federica Di Tella 1, Donatella Cicia 1, Ruggero Lionetti 5, Alexandros Makriyannis 6, Michael Malamas 6, Marcello De Luca 5, Giovanni Aprea 7, Maria D'Armiento 8, Raffaele Capasso 9 2, Bernardo Sbarro 1, Tommaso Venneri 1 2, Vincenzo Di Marzo 3 10 11 2, Francesca Borrelli 1 2, Angelo A Izzo 1 2/titolo:NAAA is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth/doi:/rivista:British journal of pharmacology/anno:2021/pagina_da:/pagina_a:/intervallo_pagine:/volume

Background and purpose: N-acylethanolamine acid amidase (NAAA) is a lysosomal enzyme accountable for the breakdown of N-acylethanolamides (NAEs) and its pharmacological inhibition determines beneficial effects in inflammatory conditions. The knowledg

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::3e4aac930f29aa874cab6dc79e2d4b1f
http://www.cnr.it/prodotto/i/460792